Home LiteratureArticle Details
PMID: 8473509 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control mice.

The Journal of clinical investigation ·Vol. 91 ·No. 4 ·1993-04-00 ·Pages 1665-71

Hayek T, Ito Y, Azrolan N, Verdery RB, Aalto-Setälä K, Walsh A, Breslow JL

Abstract

In humans, diets high in saturated fat and cholesterol raise HDL-cholesterol (HDL-C) levels. To explore the mechanism, we have devised a mouse model that mimics the human situation. In this model, HuAITg and control mice were studied on low fat (9% cal)-low cholesterol (57 mg/1,000 kcal) (chow) and high fat (41% cal)-high cholesterol (437 mg/1,000 kcal) (milk-fat based) diets. The mice responded to increased dietary fat by increasing both HDL-C and apo A-I levels, with a greater increase in HDL-C levels. This was compatible with an increase in HDL size observed by nondenaturing gradient gel electrophoresis. Turnover studies with doubly labeled HDL showed that dietary fat both increase the transport rate (TR) and decreased the fractional catabolic rate of HDL cholesterol ester (CE) and apo A-I, with the largest effect on HDL CE TR. The latter suggested that dietary fat increases reverse cholesterol transport through the HDL pathway, perhaps as an adaptation to the metabolic load of a high fat diet. The increase in apo A-I TR by dietary fat was confirmed by experiments showing increased apo A-I secretion from primary hepatocytes isolated from animals on the high fat diet. The increased apo A-I production was not associated with any increase in hepatic or intestinal apo A-I mRNA, suggesting that the mechanism of the dietary fat effect was posttranscriptional, involving either increased translatability of the apo A-I mRNA or less intracellular apo A-I degradation. The dietary fat-induced decrease in HDL CE and apo A-I fractional catabolic rate may have been caused by the increase in HDL particle size, as was suggested by our previous studies in humans. In summary, a mouse model has been developed and experiments performed to better understand the paradoxical HDL-raising effect of a high fat diet.

MeSH Terms
Animals Apolipoprotein A-I/genetics,metabolism Biological Transport Cholesterol Esters/metabolism Dietary Fats/pharmacology Humans Intestinal Mucosa/metabolism Lipoproteins, HDL/blood,metabolism Liver/metabolism Mice Mice, Transgenic Models, Biological RNA, Messenger/analysis
Chemicals
Apolipoprotein A-I Cholesterol Esters Dietary Fats HDL cholesteryl ester Lipoproteins, HDL RNA, Messenger
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Hayek T
Laboratory of Biochemical Genetics and Metabolism, Rockefeller University, New York 10021-6399.
Ito Y
Azrolan N
Verdery R B
Aalto-Setälä K
Walsh A
Breslow J L
References (36)
36 references, click to expand
  1. Characterization of human high-density lipoproteins by gradient gel electrophoresis.
    Biochim Biophys Acta. 1981 Sep 24;665(3):408-19 PMID: 7295744
  2. Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters.
    Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6731-5 PMID: 1907375
  3. Regulation of intestinal and hepatic apoprotein synthesis after chronic fat and cholesterol feeding.
    J Clin Invest. 1988 May;81(5):1615-20 PMID: 3130399
  4. High-density lipoprotein--the clinical implications of recent studies.
    N Engl J Med. 1989 Nov 9;321(19):1311-6 PMID: 2677733
  5. High density lipoprotein metabolism in a rabbit model of hyperalphalipoproteinemia.
    Atherosclerosis. 1989 Mar;76(1):9-19 PMID: 2920068
  6. Intrahepatic assembly of very low density lipoproteins. Rate of transport out of the endoplasmic reticulum determines rate of secretion.
    J Biol Chem. 1987 Dec 5;262(34):16394-402 PMID: 3680257
  7. High density lipoprotein metabolism in man.
    J Clin Invest. 1977 Oct;60(4):795-807 PMID: 197124
  8. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women.
    J Clin Invest. 1989 Jul;84(1):262-9 PMID: 2500457
  9. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.
    J Clin Invest. 1991 Feb;87(2):536-44 PMID: 1899429
  10. Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primary cultures of rat hepatocytes.
    Metabolism. 1986 Dec;35(12):1128-36 PMID: 3537632
  11. Differential effects of dietary fat on the tissue-specific expression of the apolipoprotein A-I gene: relationship to plasma concentration of high density lipoproteins.
    J Lipid Res. 1989 Sep;30(9):1397-403 PMID: 2513367
  12. The effects of low cholesterol, high polyunsaturated fat, and low fat diets on plasma lipid and lipoprotein cholesterol levels in normal and hypercholesterolemic subjects.
    Am J Clin Nutr. 1981 Sep;34(9):1758-63 PMID: 6945041
  13. Dietary fatty acids and dietary cholesterol differ in their effect on the in vivo regulation of apolipoprotein A-I and A-II gene expression in inbred strains of mice.
    Biochim Biophys Acta. 1992 May 8;1125(3):251-61 PMID: 1596514
  14. Adipose-tissue fatty acid composition in recipients of long-term total parenteral nutrition (TPN).
    Am J Clin Nutr. 1991 Jun;53(6):1487-92 PMID: 1903586
  15. Immunochemical measurement of apolipoprotein synthesis in cell and organ culture.
    Methods Enzymol. 1986;129:254-71 PMID: 3523147
  16. The theory of tracer experiments with 131I-labelled plasma proteins.
    Phys Med Biol. 1957 Jul;2(1):36-53 PMID: 13484460
  17. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.
    J Clin Invest. 1990 Aug;86(2):379-84 PMID: 2200802
  18. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.
    Circulation. 1986 Dec;74(6):1217-25 PMID: 3536151
  19. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.
    Biochim Biophys Acta. 1972 Feb 21;260(2):212-21 PMID: 4335139
  20. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.
    Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):434-8 PMID: 1703299
  21. Comparison of gradient gel electrophoresis and zonal ultracentrifugation for quantitation of high density lipoproteins.
    J Lipid Res. 1985 Nov;26(11):1363-7 PMID: 4067424
  22. Identification of a cDNA clone for mouse apoprotein A-1 (apo A-1) and its use in characterization of apo A-1 mRNA expression in liver and small intestine.
    Proc Natl Acad Sci U S A. 1983 Mar;80(6):1511-5 PMID: 6572912
  23. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.
    J Clin Invest. 1992 Aug;90(2):505-10 PMID: 1644921
  24. Phenotypic characterization of the Ath-1 gene controlling high density lipoprotein levels and susceptibility to atherosclerosis.
    J Lipid Res. 1990 Jan;31(1):91-101 PMID: 2107272
  25. Probucol decreases apolipoprotein A-I transport rate and increases high density lipoprotein cholesteryl ester fractional catabolic rate in control and human apolipoprotein A-I transgenic mice.
    Arterioscler Thromb. 1991 Sep-Oct;11(5):1295-302 PMID: 1911715
  26. A solution hybridization/RNase protection assay with riboprobes to determine absolute levels of apoB, A-I, and E mRNA in human hepatoma cell lines.
    J Lipid Res. 1990 Jun;31(6):1141-6 PMID: 2165116
  27. High density lipoprotein metabolism.
    J Lipid Res. 1984 Oct;25(10):1017-58 PMID: 6392459
  28. Effect of egg cholesterol and dietary fats on plasma lipids, lipoproteins, and apoproteins of normal women consuming natural diets.
    J Lipid Res. 1987 May;28(5):518-27 PMID: 3598397
  29. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.
    JAMA. 1986 Nov 28;256(20):2835-8 PMID: 3773200
  30. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.
    J Clin Invest. 1990 Jan;85(1):144-51 PMID: 2104877
  31. Effects of a low fat diet with and without intermittent saturated fat and cholesterol ingestion on plasma lipid, lipoprotein, and apolipoprotein levels in normal volunteers.
    J Lipid Res. 1988 Jul;29(7):963-9 PMID: 3411252
  32. Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I.
    J Clin Invest. 1978 Jun;61(6):1582-92 PMID: 207739
  33. Measurement of normative HDL subfraction cholesterol levels by Gaussian summation analysis of gradient gels.
    J Lipid Res. 1989 Jul;30(7):1085-95 PMID: 2794791
  34. High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3.
    J Biol Chem. 1989 Apr 15;264(11):6488-94 PMID: 2495286
  35. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
    Anal Biochem. 1987 Apr;162(1):156-9 PMID: 2440339
  36. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis.
    Am Heart J. 1987 Feb;113(2 Pt 2):589-97 PMID: 3544775
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1993-04-00
Pages
1665-71
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC288145
Subset
IM
Grants
NCI NIH HHS · P01 CA29502 · United States
NHLBI NIH HHS · R01 HL-32435 · United States
NHLBI NIH HHS · R01HL-33714 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com